The website of an orthopaedic sports medicine surgeon offering platelet and cord blood injections; the addresses on it are now in Texas, not Minnesota.
This is the practice website of Kelechi R. Okoroha, MD, an orthopaedic surgeon specialising in sports medicine, with a focus on the hip, knee, shoulder and elbow. The site lists his professional memberships as the American Medical Association, the American Shoulder and Elbow Surgeons, the International Society for Hip Arthroscopy Surgery, the Alpha Kappa Mu honour society and the Arthroscopy Association of North America.
There is an important discrepancy to flag. This directory lists the practice in Minneapolis, St Paul and Rochester, Minnesota, but every address on the site itself is in Texas: 1801 Inwood Road in Dallas, 3030 Waterview Parkway in Richardson, and 12500 Dallas Parkway in Frisco. Many pages still carry Minnesota place names in their titles and web addresses, which suggests the practice has relocated and the site has been only partly updated. Anyone in Minnesota should confirm where he now practises before trying to book.
On regenerative treatment the site names stem cell therapy and platelet rich plasma (PRP, prepared from the patient's own blood). It has a separate page on umbilical cord stem cells, which it describes as coming from umbilical cord blood, and it names Liveyon as the manufacturer of the product used. That page states that cord blood contains ten times more stem cells than adult bone marrow, that cord cells rarely carry infectious disease, and that they lack abnormalities caused by environmental toxins. Those are claims made on the site; they are reported here rather than endorsed, and the page does not describe how the material is collected, screened or tested.
The conditions that cord blood page names — anaemia, autoimmune disease, leukaemia and degenerative disease — go well beyond the orthopaedic work described elsewhere on the site, and blur an important distinction between long-established bone marrow and cord blood transplantation for blood disorders and the quite different use of cord products as joint injections. The site gives no prices, no founding year and no languages. Anyone considering treatment should ask which product would be used, whether it is allogeneic (from a donor), and what its regulatory position is.
The orthopaedic pages cover joint and sports injuries; the umbilical cord page names a much broader and quite different set of conditions.
The site names both the patient's own blood platelets and an umbilical cord blood product supplied by an outside manufacturer.
This is a single-surgeon practice website.
The site lists three offices, all in Texas: 1801 Inwood Road, 1st Floor, Dallas; 3030 Waterview Parkway, Richardson; and 12500 Dallas Parkway, 3rd Floor, Frisco. No Minnesota address appears in the content, despite Minnesota place names persisting in many page titles and web addresses. Nothing is described about the premises themselves, injection or theatre facilities, laboratory arrangements or accreditation, and the cord blood product is said to come from an outside manufacturer rather than being prepared on site.
The site publishes no prices and says nothing about insurance or self-pay arrangements. Cost would have to be established by contacting the practice — which, on the site's own addresses, means a Texas office.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.